1

                                                                   Exhibit 99.01


                              CARDINAL HEALTH, INC.
                 STATEMENT REGARDING FORWARD-LOOKING INFORMATION



     The Private Securities Litigation Reform Act of 1995 (the "Act") provides a
"safe harbor" for "forward-looking statements" (as defined in the Act). The Form
10-Q to which this exhibit is attached, the Company's Annual Report to
Shareholders, any Form 10-K or any Form 8-K of the Company, or any other written
or oral statements made by or on behalf of the Company may include
forward-looking statements which reflect the Company's current view (as of the
date such forward-looking statement is made) with respect to future events and
financial performance. These forward-looking statements are subject to certain
uncertainties and other factors that could cause actual results to differ
materially from those made in such statements. These uncertainties and other
factors include, but are not limited to, uncertainties relating to general
economic conditions; the loss of one or more key customer or supplier
relationships, including pharmaceutical manufacturers for which alternative
supplies may not be available; the malfunction or failure of the Company's
information systems; the costs and difficulties related to the integration of
recently acquired businesses; changes in the distribution or outsourcing pattern
for pharmaceutical products, including any increase in direct distribution or
decrease in contract packaging by pharmaceutical manufacturers; changes in, or
failure to comply with, government regulations; the costs and other effects of
legal and administrative proceedings; injury to person or property resulting
from the Company's repackaging or pharmacy management services; competitive
factors in the Company's healthcare service businesses, including pricing
pressures; the continued financial viability and success of the Company's
customers, suppliers, and franchisees; technological developments and products
offered by competitors; failure to retain or continue to attract senior
management or key personnel; risks associated with international operations,
including fluctuations in currency exchange ratios; successful challenges to the
validity of the Company's patents, copyrights and/or trademarks; difficulties or
delays in the development, production and marketing of new products and
services; strikes or other labor disruptions; labor and employee benefit costs;
pharmaceutical manufacturers' pricing policies and overall drug price inflation;
changes in hospital buying groups or hospital buying practices; and other
factors referenced in the Form 10-Q to which this exhibit is attached or other
filings or written or oral statements made by or on behalf of the Company. The
words "believe", "expect", "anticipate", "project", and similar expressions
identify "forward-looking statements", which speak only as of the date the
statement was made. The Company undertakes no obligation to publicly update or
revise any forward-looking statements, whether as a result of new information,
future events or otherwise.


                                    Page 13